Topics
April 2018 | Cover Focus: On The Case
RVO Overview
Epidemiology, risk factors, and clinical features of this common cause of retinal vascular disease.
Thomas Jenkins, MD; Daniel Su, MD; and Michael A. Klufas, MD
October 9, 2026
Perceive Bio Completes Phase 2a Enrollment in VOY-101 Gene Therapy Study for Geographic Atrophy
Haag-Streit Launches Eyesi Surgical 3.0 Virtual Reality Training Platform at AAO
October 7, 2026
Atsena Reports Preliminary ATSN-201 Results in X-linked Retinoschisis
Study Links GLP-1 Use to Earlier Fellow-Eye NAION Involvement
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
